The IIT Roorkee study on Efavirenz offers a new avenue for Chikungunya treatment, bringing optimism to patients and doctors ...

Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, saying they are "doing catastrophic harm" to the global fight against AIDS.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

In a nutshell When the Doomsday Clock moves closer to midnight, researchers found significant increases in suicide rates, Alzheimer’s disease mortality, and substance-related deaths across a 70-year ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Unlike President Trump's picks to lead other health agencies who established their conservative bona fides during the ...

Primarily a grantmaking agency with an $8 billion budget, SAMHSA channels funds and training that the federal government ...

Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops ...

Disparities in HIV diagnosis rates were observed between Black and White individuals in the US from 2017 to 2021.